Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
7 Leser
Artikel bewerten:
(0)

IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales

MOUNTAIN VIEW, Calif., Nov. 7, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today announced that, effective immediately, it has promoted sales and marketing executive Timothy D. Buckley to Vice President of Marketing and North American Sales. Buckley had previously taken over interim responsibility for domestic sales earlier this year, and will continue to report directly to James H. Mackaness, Chief Financial Officer and Chief Operating Officer.

Buckley, 38, has more than 16 years of experience in the medical device industry, including roles in sales, marketing and product development within the ophthalmology industry, for industry leaders such as Carl Zeiss Meditec and transformative start-ups such as Transcend Medical. He is the former CEO and co-founder of Alamo, CA-based Ocunetics, and joined IRIDEX in September 2011 when Ocunetics licensed its technologies to IRIDEX.

"Tim's efforts have been very impressive and I am confident that under his leadership the marketing and sales teams will continue to build on the momentum and the successes they have shown during the first nine months of 2013," Mackaness said. "We have enjoyed an excellent year at IRIDEX, and Tim has played an important role in our efforts."

Buckley will be responsible for worldwide marketing and all North American sales, including direct and independent sales forces in the U.S. and the Company's distribution effort in Canada.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at http://www.iridex.com/.

SOURCE IRIDEX Corporation

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.